C

CVS Health

Healthcare, insurance, PBM, and retail pharmacy

Large Group Pricing Actuary

Full-TimePosted on 10/1/2026Deadline 10/30/26
$118.5k - $260.6k/yr+ Bonus + Commission + Short-term incentive + Equity award
Senior
Bachelor's
Blue Bell, PA, USA+3 moreMore locations: Hartford, CT, USA | Woonsocket, RI, USA | Irving, TX, USA
HybridRemote or hybrid work options are indicated; on-site schedule is unspecified.
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • Bachelor's degree and at least 5 years of actuarial experience.
  • Associate of the Society of Actuaries (ASA) designation.
  • Ability to thrive in an evolving environment with competing priorities and deadlines.
  • Ability to collaborate with key stakeholders to formulate recommendations and courses of action.
Responsibilities
  • Support and evolve the Gross to Net Trend function as a foundational component of forecasting and pricing.
  • Analyze and quantify drivers of gross and net trend, assessing their financial impact and relative significance.
  • Refine Gross to Net methodologies, assumptions, and modeling approaches to improve accuracy, consistency, and credibility.
  • Partner in the monthly Gross to Net process to deliver timely insights and inform pricing recommendations.
  • Collaborate with Finance, Underwriting, Product, Network, Contracting, Sales, and market leadership to support pricing strategies and key business decisions.
  • Provide actuarial expertise on financial performance, forecasting, budgeting, rate actions, filings, and other strategic initiatives.
  • Communicate complex actuarial analyses and pricing implications to technical and non-technical stakeholders.
  • Deliver timely, responsive actuarial support aligned with business objectives.
  • Develop and enhance trend analytics, documentation, and governance to support pricing assumptions and actuarial decision-making.
  • Lead ongoing improvements to trend methodologies, tools, and team knowledge.
  • Provide senior leadership with actionable insights on trend drivers, pricing recommendations, risks, and tradeoffs.
  • Monitor industry, competitive, regulatory, and macroeconomic developments to inform trend assumptions and pricing strategies.
  • Prepare and deliver complex, high-profile actuarial work; develop creative solutions to non-standard business challenges and take ownership of the overall work product.
  • Collaborate across functions on complex initiatives and influence business decisions through clear, data-driven recommendations.
  • Review work for accuracy, identify business risks, and develop actionable recommendations; demonstrate the ability to issue Actuarial Communications under the Actuarial Standards of Practice.
  • Develop actuarial strategies using industry trends, economic factors, competitive intelligence, and business objectives; use multiple data sources and problem-solving to drive business outcomes.
  • Build consensus and resolve conflicts through written and verbal communication.
  • Lead or support departmental projects and process improvements, including automation and operational enhancements.
  • Identify development opportunities and recommend, create, and deliver training solutions.
  • Coach, mentor, and provide feedback to less experienced actuarial professionals to support technical growth and subject matter expertise.
  • Potentially manage up to two actuarial professionals.
Desired Qualifications
  • Fellow of the Society of Actuaries (FSA) designation or active progress toward the FSA designation.

About the company

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Second-quarter 2026 revenue reached $106.1 billion, and adjusted EPS rose to $2.58.
  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 and cash flow above $11.5 billion.
  • CVS launched GLP-1 support and $29 virtual visits, capturing weight-loss demand now.

What critics are saying

  • 340B restrictions hit Caremark in 2026 and management expects pressure into 2027.
  • Omnicare’s $949 million fraud case and $440 million settlement damage trust through 2028.
  • Rite Aid transfer gains fade while Walgreens closures stop, squeezing prescription-share upside.

What makes CVS Health unique

  • Caremark, Aetna, and CVS Pharmacy create unmatched insurance-to-retail integration.
  • CVS opened pharmacy-only formats in Chicago in March 2026, sharpening prescription density.
  • Teresa Heitsenrether joins the board November 2026, signaling stronger data-led operating discipline.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Sep 25th, 2026
CVS shares drop 15% as pharmacy giant warns of unquantified 340B business headwinds in 2027

CVS Health faces an unquantified headwind from its 340B drug discount programme heading into 2027, management warned during its fiscal Q2 2026 earnings call in August. The company's shares have fallen 15.2% over the past three months, even as management raised its 2026 earnings outlook. The 340B business, which serves eligible healthcare organisations, is experiencing pressure as drugmakers limit programme coverage. Management expects this drag to continue affecting its pharmacy services business in 2027 but declined to quantify the potential impact. CVS's Health Services segment, which likely includes the 340B business, generated $190.4 billion in revenue during fiscal 2025. The company trades at 22.5 times trailing earnings, roughly level with the S&P 500's 22.4 multiple.

Yahoo Finance
Sep 18th, 2026
CVS Omnicare completes $250M bankruptcy sale after $440M government settlement

CVS Health's Omnicare division has completed its Chapter 11 bankruptcy liquidation after selling its business operations for $250 million. A Texas bankruptcy judge approved the wind-down plan following a $440 million settlement with the Justice Department over improper billing practices. Omnicare, which served nursing homes and long-term care facilities, filed for bankruptcy in September 2025 after facing a $949 million judgement for fraudulently dispensing drugs without valid prescriptions and billing federal healthcare programmes for false claims. The settlement requires CVS to pay $130 million upfront and cover the remaining $310 million if Omnicare fails to do so by March 2028. GenieRx Holdings, a joint partnership between Milrose Capital and Integro Asset Management, purchased Omnicare's operations. The sale is expected to close next month.

Yahoo Finance
Sep 14th, 2026
CVS Health up 32% in a year: is it time to buy the stock?

CVS Health shares have declined 2.1% over the past three months, prompting investors to consider whether now is an opportune time to buy. The healthcare giant, which operates approximately 9,000 retail pharmacy locations and serves more than 35 million people through its health insurance business, reported second-quarter revenue of $106 billion, up 7.3% year-over-year. Adjusted earnings per share rose 43% in the same period. The company offers a dividend yield of 2.8%, with its annual payout increasing from $2 in 2021 to $2.66 per share recently. Shares currently trade at $95, with one analyst setting a price target of $120. The stock's forward price-to-earnings ratio of 11 sits slightly above its five-year average of 10.

Yahoo Finance
Sep 13th, 2026
US health insurers rebound as medical costs stabilise, analysts predict 16% earnings growth through 2030

The health insurance industry may have recovered from high medical costs, with analysts predicting strong growth through 2030. Morningstar forecasts 16% annual earnings per share growth for major insurers, above the industry's typical low-double-digit target. Health insurers are improving profitability by raising rates to cover increased medical utilisation. UnitedHealth Group reported over $5 billion in second-quarter net income, with its medical care ratio falling to 86.7% from 89.4% year-over-year. The outlook also improved for pharmacy benefit management operations at companies like UnitedHealth, CVS Health, and Cigna. Despite increased regulatory scrutiny, the "big three" PBMs maintain strong competitive positions. Third-quarter earnings reports next month should provide further clarity on the industry's financial health.

Yahoo Finance
Sep 12th, 2026
CVS quietly gains market share as Walgreens closes 1,200 US stores following $10B private equity sale

Walgreens is closing roughly 1,200 of its approximately 8,500 US locations through 2027, with many customers being redirected to nearby CVS pharmacies. The pattern is reshaping suburban pharmacy markets without direct competition. In August 2025, Walgreens completed a $10 billion sale to private equity firm Sycamore Partners, taking the 124-year-old chain private for the first time. Mike Motz was named chief executive, replacing Tim Wentworth. CVS is gaining market share without active expansion efforts. Federal and state rules require orderly prescription transfers when pharmacies close, often directing patients to the nearest CVS location. CVS and Walgreens together now handle nearly 40% of all US retail prescription sales. CVS benefits from owning Caremark, a dominant pharmacy benefit manager, providing vertical integration advantages.